knowledge -WSS

knowledge

author：explore 2025-09-29 22:50:55 - browse：85762

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Dems pitch expanding Medicare power to negotiate drug prices

hotspot

WSS

Kenai launches with $82 million for Parkinson’s stem cell therapy

CDC Director Mandy Cohen on transparency, trust, and health

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Search called off for baby washed away in Pennsylvania flash flood

The battle over 'scope creep' and who gets to be called 'doctor'

Roche’s Alnylam deal shows drug firms interested in heart drugs

hotspot

knowledge

focus

In Memoriam: Notable people who died in 2023

UHS says company favors patients whose insurance pays more

Guidelines to prevent youth baseball injuries need more muscle

A new crop of companies is reshaping the health data economy

Medical leaders decry Supreme Court decision on affirmative action

Biden warns of ‘dark winter’ during final presidental debate

Drug repurposing or repositioning? The language matters

International team creates first chimeric human

The cancer drug shortage isn’t new — and neither are the solutions

STAT Report: Patient voices and perspectives

entertainment

FDA does about

STAT Report: Patient voices and perspectives

International team creates first chimeric human

In the gardens at Boston Children's Hospital, families find sanctuary

UHS says company favors patients whose insurance pays more

New Alzheimer's drugs heat up race for early detection blood tests

explore

focus

hotspot

knowledge